Abstract
Co-morbid major depression occurs in approximately 10% of people suffering from a chronic medical condition such as cancer. Systematic integrated management that includes both identification and treatment has been advocated. However, we lack information on the cost-effectiveness of this combined approach, as published evaluations have focused solely on the systematic (collaborative care) treatment stage. We therefore aimed to use the best available evidence to estimate the cost-effectiveness of systematic integrated management (both identification and treatment) compared with usual practice, for patients attending specialist cancer clinics.
Original language | English |
---|---|
Pages (from-to) | 1451-1460 |
Number of pages | 10 |
Journal | Psychological Medicine |
Volume | 44 |
Issue number | 7 |
Early online date | 21 Aug 2013 |
DOIs | |
Publication status | Published - Apr 2014 |